SPR Therapeutics, Inc. is a privately-held medical device company committed to improving the lives of millions of pain sufferers with its peripheral nerve stimulation (PNS) platform technology poised to be the standard of care and ultimately, the treatment of choice for pain management. Led by a world-class team of scientists, physicians, and business professionals with a track record of commercializing innovative neurostimulation products, SPR’s PNS therapy for acute and chronic pain management provides a non-narcotic, reversible, safe, effective and more affordable alternative to addictive opioid medications and invasive surgeries.

SPR is focused on developing, manufacturing and commercializing non-opioid, minimally invasive, treatment options that improve quality of life. Its SPRINT technology is the only percutaneous Peripheral Nerve Stimulation (PNS) System cleared to treat both chronic and acute pain.